Article Details

Eiger Biopharmaceuticals (EIGR) Received its Third Buy in a Row

Retrieved on: 2021-03-11 12:56:15

Tags for this article:

Click the tags to see associated articles and topics

Eiger Biopharmaceuticals (EIGR) Received its Third Buy in a Row. View article details on hiswai:

Excerpt

After Ladenburg Thalmann & Co. and Wedbush gave Eiger Biopharmaceuticals (NASDAQ: EIGR) a Buy rating last month, the company received ...

Article found on: www.smarteranalyst.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up